The "2023 Hurun Global Future Unicorn" list has been released, and SceneRay Medical is honored to be on the list!

The Hurun Research Institute, in collaboration with the Hainan Free Trade Port Ecological Software Park, recently released the "2023 Hurun Global Future Unicorns" list, highlighting high-growth companies with valuations between US$500 million and US$1 billion—Future Unicorns. SceneRay Medical, recognized as a Future Unicorn for its innovative technology, advanced products, and reliable services, was honored on the list alongside 688 companies from 39 countries across various industries and sectors.

中国唯一一家入选“未来独角兽”的脑科学领域医疗器械生产企业

A total of 218 Chinese companies made the list, including 12 medical device manufacturers. SceneRay Medical is one of them and the only innovative R&D company focused on brain science. Future unicorns represent the development and trends of companies. As a selected company, SceneRay Medical has played an innovative and leading role in the field of brain science. Behind this rapid growth is the strong development of independent core technologies and the ultimate pursuit of product and solution experience.

Being on the list this time is not the end, but a sign of looking into the future.